Prelude Capital Management’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-839
| Closed | -$445K | – | 1230 |
|
|
2024
Q4 | $445K | Buy |
+839
| New | +$473K | 0.03% | 637 |
|
|
2024
Q3 | – | Sell |
-487
| Closed | -$264K | – | 1303 |
|
|
2024
Q2 | $264K | Buy |
+487
| New | +$279K | 0.02% | 849 |
|
|
2024
Q1 | – | Sell |
-900
| Closed | -$526K | – | 1338 |
|
|
2023
Q4 | $526K | Buy |
+900
| New | +$504K | 0.03% | 489 |
|
|
2023
Q3 | – | Sell |
-888
| Closed | -$481K | – | 1158 |
|
|
2023
Q2 | $481K | Buy |
+888
| New | +$485K | 0.03% | 478 |
|
|
2023
Q1 | – | Sell |
-968
| Closed | -$494K | – | 1212 |
|
|
2022
Q4 | $494K | Buy |
968
+370
| +62% | +$180K | 0.03% | 578 |
|
|
2022
Q3 | $261K | Buy |
+598
| New | +$288K | 0.01% | 938 |
|
|
2022
Q1 | – | Sell |
-716
| Closed | -$379K | – | 1873 |
|
|
2021
Q4 | $379K | Buy |
+716
| New | +$344K | 0.01% | 1181 |
|
|
2021
Q1 | – | Sell |
-382
| Closed | -$203K | – | 1565 |
|
|
2020
Q4 | $203K | Buy |
+382
| New | +$188K | 0.01% | 1112 |
|
|
2020
Q2 | – | Sell |
-341
| Closed | -$148K | – | 1980 |
|
|
2020
Q1 | $148K | Buy |
341
+141
| +71% | +$63K | 0.01% | 503 |
|
|
2019
Q4 | $88K | Sell |
200
-90
| -31% | -$37.9K | ﹤0.01% | 1155 |
|
|
2019
Q3 | $121K | Buy |
290
+90
| +45% | +$36.7K | 0.01% | 891 |
|
|
2019
Q2 | $72K | Buy |
+200
| New | +$66.8K | ﹤0.01% | 1037 |
|
|
2018
Q3 | – | Sell |
-303
| Closed | -$98K | – | 1749 |
|
|
2018
Q2 | $98K | Buy |
+303
| New | +$94.8K | 0.01% | 928 |
|
|
2017
Q1 | – | Sell |
-44
| Closed | -$7K | – | 1522 |
|
|
2016
Q4 | $7K | Sell |
44
-935
| -96% | -$137K | ﹤0.01% | 1407 |
|
|
2016
Q3 | $138K | Buy |
979
+750
| +328% | +$104K | 0.01% | 705 |
|
|
2016
Q2 | $31K | Buy |
+229
| New | +$30.4K | ﹤0.01% | 1155 |
|
|
2016
Q1 | – | Sell |
-33
| Closed | -$5K | – | 1289 |
|
|
2015
Q4 | $5K | Buy |
33
+6
| +22% | +$887 | ﹤0.01% | 1318 |
|
|
2015
Q3 | $4K | Buy |
+27
| New | +$3.78K | ﹤0.01% | 1405 |
|
|
2015
Q2 | – | Sell |
-400
| Closed | -$48K | – | 1734 |
|
|
2015
Q1 | $48K | Buy |
+400
| New | +$44.4K | 0.01% | 1301 |
|
|
2014
Q4 | – | Sell |
-400
| Closed | -$41K | – | 1928 |
|
|
2014
Q3 | $41K | Buy |
+400
| New | +$40.5K | 0.01% | 1450 |
|
|
2014
Q1 | – | Sell |
-500
| Closed | -$38K | – | 1889 |
|
|
2013
Q4 | $38K | Buy |
500
+100
| +25% | +$7.37K | 0.01% | 1126 |
|
|
2013
Q3 | $29K | Buy |
+400
| New | +$28.5K | ﹤0.01% | 1161 |
|
Other funds holding CHE
Prelude Capital Management's CHE Position: Q1 2025 in Review
Prelude Capital Management sold out of Chemed (CHE) in Q1 2025, closing a stake of 839 shares — an estimated $445K sold.
Prelude Capital Management first reported a position in CHE in Q3 2013 and held it in 22 quarters. The position peaked at $526K in Q4 2023. 554 funds tracked by Wall St. Rank hold CHE as of Q1 2025.
- Prelude Capital Management reported no remaining Chemed position as of Q1 2025 after selling out during the quarter.
- Prelude Capital Management sold 839 Chemed shares in Q1 2025, an estimated $445K.
- Prelude Capital Management first reported a position in Chemed in Q3 2013 and held it in 22 quarters.
- Prelude Capital Management's Chemed position peaked at $526K in Q4 2023.
- 554 funds tracked by Wall St. Rank held Chemed as of Q1 2025.
Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.